Splenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance.
Ontology highlight
ABSTRACT: Disease progression and relapse of chronic myeloid leukemia (CML) are caused by therapy resistant leukemia stem cells (LSCs), and cure relies on their eradication. The microenvironment in the bone marrow (BM) is known to contribute to LSC maintenance and resistance. Although leukemic infiltration of the spleen is a hallmark of CML, it is unknown whether spleen cells form a niche that maintains LSCs. Here, we demonstrate that LSCs preferentially accumulate in the spleen and contribute to disease progression. Spleen LSCs were located in the red pulp close to red pulp macrophages (RPM) in CML patients and in a murine CML model. Pharmacologic and genetic depletion of RPM reduced LSCs and decreased their cell cycling activity in the spleen. Gene expression analysis revealed enriched stemness an
SUBMITTER: Buhrer ED
PROVIDER: S-EPMC7613762 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA